维普期刊资源整合服务平台（V6.5）

97篇 您的检索式：作者名="Farinati F"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Helicobacter pylori CagA status,mucosal oxidative damage and gastritis phenotype:a potential pathway to cancer?显示文摘	Farinati F Cardin R Russo VM	2003	Helicobacter2003，8，3：	1
2	TACE treatment in hepatoeellular carcinoma: what should we do now显示文摘	Farinati F Giacomin A Vanin V	2012	J Hep- atol2012，57，1：	1
3	Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma:both or neither显示文摘	Farinati F Marino D De Giorgio M	2006	Am J Gastroenterol2006，101，3：	1
4	How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system 显示文摘	Farinati F Rinaldi M Gianni S	2000	Cancer2000，89，11：	1
5	Gastric epifhelial dysplasia,how clinico-pathologic background relates to management显示文摘	Leandto G Farinati F	1995	Cancer1995，76，：	1
6	Oxidative DNA damage accumulation in gastric carcinogenesis 显示文摘	Farinati F Orkixz S Bartel H	1998	Gut1998，42，3：	1
7	TACE treatment in hepatocellular carcinoma,what should we do now显示文摘	Farinati F Giacomin A Vanin V	2012	J Hepatol2012，57，：	1
8	Non-invasive neoplasia of the stomach显示文摘	Rugge M Nitti D Farinati F	2005	Eur J Gastroenterol Hepatol2005，17，11：	1
9	The role of cathepsins and the plasminogen actionary inhibitior systemin olorectal cancer 显示文摘	Herszyi L Farinati F PLebani M	1999	Orv Hetil1999，140，33：	1
10	Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma:both or neither?显示文摘	Farinati F Marino D De Giorgio M	2006	Am J Gastroenterol2006，101，：	1
11	CA50 detemination in body fluids:can we screen patients at risk for gastric cancer?显示文摘	Farinati F Holmogren J Di-MarioF	1991	Int J Cancer1991，47，1：	1
12	The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer显示文摘	Herszenyi L Farinati F Plebani M	1999	Orv Hetil1999，140，33：	1
13	Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma:Implications for its clinical use显示文摘	Giannini EG Sammito G Farinati F	2014	Cancer2014，120，14：	1
14	Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis显示文摘	Farinati F Cardin R Fiorentino M	2001	J Viral Heapt2001，8，1：	1
15	Diagnostic and prognostic role of a-fetoprotein in hepatocellular carcinoma:both or neither显示文摘	Farinati F Marino D de Giorgio M	2006	Am J Gastroenterol2006，101，3：	1
16	Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma:implications for its clinical use显示文摘	Giannini EG Sammito G Farinati F	2014	Cancer2014，120，14：	1
17	CA 19-9 determination in gastric juice: role in identifying gastric cancer and high risk patients显示文摘	Farinati F Nitti D Cardin F	1988	Eur J Cancer Clin Oncol1988，24，5：	1
18	Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen显示文摘	Farinati F Salvagnini M de Maria N	1990	J Hepatol1990，11，3：	1
19	Liver transplantation lbr hepatocellular carcinoma in clinical practice:The lesson from a 20 -year multieentre experience in Italy 显示文摘	Farinati F Giacomin A Vanin V	2012	Eur J Gastroenterol ttepatol2012，24，：	1
20	BCLC stage B hepatocellularcarcinoma and transcatheter arterial chemoembolization :a 20 - yearsurvey by the Italian Liver Cancer group 显示文摘	Farinati F Vanin V Giacomin A	2015	Liver Int2015，35，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示